Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by increased susceptibility to cutaneous viral infections. Type 2 (T2) immunity predominates in AD skin lesions, but expression profiling has demonstrated involvement of Type 1 (T1) and/or Type 3 (T3) cytokines. We investigated whether these cell-mediated immune pathways effect cutaneous viral infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
